ingestible sensor

'Digital pill' maker Proteus Digital Health files for bankruptcy
By Dave Muoio | 03:51 pm | June 16, 2020
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
Texas-based Children's Health pilots Proteus' ingestible sensor pills for heart transplant patients
By Laura Lovett | 04:58 pm | October 10, 2018
The ingesitble sensors will let providers look at adherence habits, activity levels and resting heart rate within a younger patient population. 
New ingestible sensor could help researchers learn more about the gut
By Jonah Comstock | 02:12 pm | January 10, 2018
A group of researchers at RMIT University in Melbourne, Australia have developed a new ingestible sensor for a novel purpose: investigating the microbiome and gasses in the gut.
California hospital becomes first in US to prescribe ingestible sensors from Proteus
By Jonah Comstock | 11:36 am | January 11, 2016
Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients.
Proteus, Otsuka submit first commercial drug with built-in sensor to FDA
By Jonah Comstock | 06:59 am | September 10, 2015
After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to incorporate Proteus's ingestible sensor.
Proteus Digital Health study finds system detects pill ingestion 99.1 percent of the time
By Aditi Pai | 09:40 am | August 05, 2014
Proteus Digital Health Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 patients who used the system over 5,656 days.